MIDA Biotech B.V. is an innovative company focused on stem cell therapy, specializing in research and development for aging disorders, injuries, and degenerative diseases. Located in the Leiden Bioscience Park, MIDA is pioneering novel stem cell-based technologies and therapeutics, leveraging microfluidic technology for personalized iPS cells and developing therapies for neurodegenerative diseases and age-related disorders. The company aims to create facilities that support other biotech firms through advancements in manufacturing technologies, positioning itself as a key player in the life sciences sector.
Something looks off?